Protagonist Therapeutics

Protagonist Therapeutics

Protagonist Therapeutics

Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Founded
2001
Raised
$63M
Follow us
Alexa global traffic share